Stockwinners Market Radar for August 30, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:53 EDT Mosaic reports July Potash revenue $391M vs. $191M y/y - Reports July Phosphates revenue $295M vs. $407M y/y and Mosaic Fertilizantes revenue $848M vs. $585M y/y

18:26 EDT HP Inc. CEO: Supply chain situation is 'getting closer to normal' - In an interview on CNBC's Mad Money, Enrique Lores said Q3 revenue was impacted by a slowdown of consumer demand which he believes is temporary. He noted that customers are being careful with hiring and overall staffing levels. Lores continues to believe HP shares are a good investment. He added that the company is in a much better situation now than a year ago regarding the supply chain, and it is slowly getting back to normal. HP continues to have strong margins on the print side, he added, and it's doing a very good job managing prices.

17:45 EDT New Age Beverages trading resumes

17:35 EDT Boeing awarded $5.02B Missile Defense Agency contract - Boeing was awarded an indefinite-delivery/indefinite-quantity contract with a maximum dollar amount of $5.02B. Under this new contract, the system integration, test, and readiness contractor is responsible for overall Ground-Based Midcourse Defense Element engineering, integration including physical and logical integration of the GMD Element and components and GMD integration with the Missile Defense System; and planning, and execution of all necessary testing to verify overall requirements compliance. In addition, SITR is responsible for day-to-day systems operations and readiness, performs routine maintenance functions, performs analysis related to GMD Element health and availability, and executes failure/fault checklists, as appropriate. A task order in the amount of $506.67M is being issued at this time. The work will be performed primarily in Huntsville, Alabama. The ordering period is from September 1 through August 31, 2027. This contract was competitively procured via publication on the government-wide Point of Entry website with three proposals received. FY22 research, development, test and evaluation funds in the amount of $4.55M are being obligated on this award. The Missile Defense Agency is the contracting activity.

17:32 EDT Raytheon Technologies awarded $972.18M Air Force contract modification - Raytheon has been awarded a $972.18M non-competitive, firm-fixed-price incentive modification to a previously awarded contract for Advanced Medium Range Air-to-Air Missile, or AMRAAM, Production Lot 36. The modification provides for the exercise of the pre-priced options for Lot 36 production of AMRAAM missiles, AMRAAM Telemetry System, or ATS, initial and field spares, and other production engineering support hardware and activities. Work is expected to be completed by August 30, 2025. This contract involves Foreign Military Sales to Australia, Bahrain, Bulgaria, Canada, Denmark, Finland, Hungary, Italy, Japan, Korea, Netherlands, Norway, Qatar, Saudi Arabia, Singapore, Slovakia, Spain, Switzerland, and the United Kingdom, which accounts for 42% of the contract value. Air Force Life Cycle Management Center is the contracting activity.

17:29 EDT Chewy sees FY22 adjusted EBITDA margin 1.75%-2% - Sees FY22 gross margin expansion of 30-50 basis points from last year. Says business model produces sticky customers. Says will keep adding capacity to Chewy Freight Services program. Says pleased with the initial customer response to its bespoke insurance and standalone wellness plans. Says benefits from automation continue to expand across the network and pace of realizing benefits continues to accelerate. Says some costs will catch up to price increases in Q3. Says expects advertising and marketing to continue to be 5%-7% of net sales. Comments and guidance taken from Q2 earnings conference call.

17:23 EDT NewAge to resume trading at 17:45ET

17:16 EDT Privia Health reports results in CMS' Medicare shared savings program - The company states: "Privia Health Group announced that its Accountable Care Organizations delivered quality care and improved patient outcomes, and achieved shared savings of $99.9M through the Medicare Shared Savings Program. Privia's ACOs provided high-value, cost-efficient care to more than 112,000 Medicare beneficiaries in 2021. For the 2021 performance year, Privia Quality Network included physicians and advanced practitioners in Georgia, Maryland, Texas, Virginia and Washington, DC. Since 2014, Privia Quality Network has delivered total shared savings across government programs and commercial payers of more than $740M, including more than $380M through participation in the MSSP."

17:03 EDT Algonquin Power appoints Darren Myers as CFO - Algonquin Power & Utilities (AQN) announced that it has appointed Darren Myers CFO. This follows the decision of Arthur Kacprzak to step down from this role effective immediately. Mr. Kacprzak has agreed to remain with the Company in an advisory capacity through the end of 2022 to support a smooth transition to his successor. Myers most recently served as Executive Vice President and CFO at Loblaw (L), Canada's largest retail company. During his tenure, he improved capital discipline, elevated the performance management system, and balanced long-term investments and earnings growth while the Company navigated challenges with market disruption and the COVID-19 pandemic. Prior to Loblaw, Myers spent 16 years at Celestica (CLS), a global supply chain and manufacturing company. He was the Executive Vice President and CFO from 2012 to 2017 including responsibility for Global Business Services and IT. As CFO, he helped the company shift its strategy to grow in new markets, drive operational execution and generate cash flow and reduce debt.

17:01 EDT Ashland announces expansion of Viatel manufacturing in Ireland - Ashland has announced a strategically significant expansion of its Viatel bioresorbable polymer manufacturing and research and development site at the National Science Park, home to a network of innovative organizations, in Mullingar, Ireland. "Doubling both our footprint, which includes manufacturing and laboratory space, and the headcount of this facility allows us to deliver cutting-edge polymer chemistry by increasing scope, capacity, and capabilities, and to respond to growing customer needs with greater speed," said Sean McMahon, Ph.D., business manager, Viatel bioresorbable polymers, Ashland. "Expansion of the facility in Ireland showcases our commitment to innovation in the long acting injectables space," said Ashok Kalyana, senior vice president and general manager, Life Sciences, Ashland. "We are actively helping our customers solve for performance attributes that will ultimately allow patients to take less medicine, fewer times." The capital expansion program commenced in June 2022 and is expected to complete in 2024.

16:44 EDT International Seaways Chairman Wheat sells over $617K in company shares - Chairman of International Seaways Douglas Wheat disclosed in a filing that he had sold 20,000 shares of company stock for $30.85 per share, on August 29, for a total transaction amount of $617,058.

16:33 EDT AMMO shareholder issues statement regarding board candidates - Steven Urvan, who owns approximately 17.1% of the outstanding common shares of AMMO, issued the following statement following its nomination of seven candidates for election to the company's board of directors at the 2022 annual meeting of shareholders: "We appreciate the positive feedback that has been proactively provided to us by our fellow shareholders. We also appreciate that the Company's August 29th press release invited 'all shareholders' to articulate their views and perspectives. Given the Company's finite resources and modest market capitalization, we hope leadership focuses on efficiently evaluating investor sentiment - not spending shareholders' precious capital on a defensive and reactionary campaign. Likewise, we urge leadership to avoid any action or transaction that dilutes shareholders ahead of the Annual Meeting. Please trust that the Urvan Group is committed to continuing to advocate for all shareholders' best interests and pursuing a value-enhancing transformation of AMMO in the public market."

16:32 EDT EyePoint gets subpoena from Mass. U.S. Attorney's Office on DEXYCU - On August 22, EyePoint Pharmaceuticals received an unsigned version of a subpoena from the U.S. Attorney's Office for the District of Massachusetts seeking production of documents related to sales, marketing and promotional practices, including as pertain to DEXYCU . The Company received a signed version of the subpoena on August 26. The Company intends to cooperate fully with the government in connection with this matter.

16:28 EDT OncoCyte announces five-year VA contract for DetermaRx - Oncocyte "announced that the U.S. Department of Veterans Affairs, the largest integrated health care system in the United States, has awarded a Federal Supply Schedule Contract for the Company's DetermaRx test. The VA provides care at 1,293 health care facilities, including 171 VA Medical Centers and 1,112 outpatient sites of care of varying complexity to over 9 million veterans enrolled in the VA health care program. The contract is for a period of five years."

16:18 EDT Balchem acquires Bergstrom Nutrition, no terms - Balchem Corporation announced the acquisition of Cardinal Associates Inc., operating as "Bergstrom Nutrition," a leading science-based manufacturer of methylsulfonylmethane , based in Vancouver, Washington.MSM is a widely used nutritional ingredient with strong scientific evidence supporting its benefits for joint health, sports nutrition, skin and beauty, healthy aging, and pet health. Bergstrom Nutrition's MSM brand "OptiMSM(R)" delivers the highest quality and purity MSM on the market and is the only brand of MSM with a U.S. GRAS "generally regarded as safe" designation.

16:15 EDT Chewy falls 12.3% after Q2 results and below-consensus guidance

16:13 EDT Chewy reports Q2 active customers 20.5M, up 2.1% y/y - Reports Q2 adjusted EBMITDA margin 3.4%, up 230bps y/y. Reports Q2 Net sales per active customer up 14.4% y/y to $462.

16:12 EDT A-Mark declares $1.00 special cash dividend, 20c quarterly dividend - A-Mark's board of directors has declared a non-recurring special cash dividend of $1.00 per common share. The special dividend will be paid on September 26 to stockholders of record as of September 12. A-Mark's board of directors has adopted a regular quarterly cash dividend policy of 20c per share. The initial quarterly cash dividend under the policy will be paid on October 24 to stockholders of record as of October 10. The declaration of regular cash dividends in the future is subject to the determination each quarter by the board of directors, based on a number of factors, including the company's financial performance, available cash resources, cash requirements and alternative uses of cash and applicable bank covenants.

16:07 EDT Inari Medical enrolls DEFIANCE trial evaluating treatment with the ClotTriever - Inari Medical, announced planned enrollment of the DEFIANCE trial. DEFIANCE is a randomized controlled trial comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis treated with the ClotTriever System versus anticoagulation only. The trial will enroll 300 patients at up to 60 centers worldwide. DEFIANCE is Inari's second RCT and it will run in parallel to the PEERLESS trial. PEERLESS commenced earlier this year and compares FlowTriever to catheter-directed thrombolytics in pulmonary embolism. "Anticoagulation is still the predominant therapy used in the management of DVT and in some studies has been associated with post-thrombotic syndrome in up to 50% of patients," said Dr. Steven Abramowitz, Co-Principal Investigatory and Chair of Vascular Surgery at MedStar Heath. "PTS is a debilitating condition with symptoms including swelling, difficulty walking, skin changes and poorly healing open wounds. Research has shown PTS quality of life scores can be as low as those of patients suffering from heart failure or cancer. Mechanical thrombectomy procedures, using technology like ClotTriever, rapidly remove large volumes of DVT and may thereby reduce the risk of PTS." "DEFIANCE is the first RCT to compare mechanical thrombectomy to anticoagulation for the treatment of DVT," said Dr. Xhorlina Marko, Co-Principal Investigator and Interventional Radiologist at Beaumont Health. "The primary endpoint for the trial is a hierarchical composite of treatment failure and PTS severity at 6 months. The trial has the potential to influence guidelines and change the standard of care."

15:01 EDT Royal Caribbean to implement SpaceX's Starlink - Royal Caribbean announced its plan to implement SpaceX's Starlink - making the Group the first in the cruise industry to adopt its high-speed, low-latency connectivity for a better onboard experience for guests and crew fleetwide. The innovative broadband internet service will be installed on all Royal Caribbean International, Celebrity Cruises and Silversea Cruises ships, along with all new vessels for each of the brands. Deployment of the Starlink technology across the fleet will begin immediately, leveraging the insights obtained from the trial onboard Freedom of the Seas, which has received tremendous positive feedback from guests and crew. The installation is slated to be completed by the end of the first quarter of 2023.

13:58 EDT Instagram tests new ways to flag posts users are not interested in - Meta's Instagram announced that it is testing two new ways to help users shape their Instagram experience. "We're testing the ability to mark multiple posts in Explore as Not Interested," the company said. "We'll immediately hide those posts and refrain from showing you similar content in the future. We'll also soon start testing the ability to tell Instagram you don't want to see suggested posts with certain words, phrases or emojis in the caption or hashtags. Whether you're seeing something that's not relevant, or have moved on from something you used to like, you can use this feature to stop seeing content that's not interesting to you." Reference Link

12:05 EDT Corteva, BASF collaborate to develop soybean weed control solutions - Corteva Agriscience and BASF announced a long-term collaboration to develop new soybean weed control solutions for farmers around the world. The two companies agreed to cross-license soybean traits, while developing complementary herbicide technologies, enabling both companies to offer innovative soybean weed management solutions. Through the collaboration, Corteva and BASF aim to meet farmers' demand for tailored weed control options differentiated from those on the market or in development. Corteva will combine a proprietary PPO gene licensed from BASF with its portfolio of herbicide tolerant traits, including Corteva's proprietary 2,4-D choline gene, to develop a new trait stack for soybeans. The stack will include tolerance to four herbicide modes of action, or distinct mechanisms to achieve control. Together they will provide a new, effective and flexible option to help control the most problematic weeds. This innovative herbicide tolerance stack is expected to be available in all Corteva seed brands. Corteva has licensed the stack to BASF for use in BASF seed brands and also anticipates licensing the trait stack to additional seed companies.

12:02 EDT Advanced Human Imaging Ltd - ADR trading halted, news pending

12:00 EDT AMTD Digital falls -20.6% - AMTD Digital is down -20.6%, or -$28.50 to $110.00.

12:00 EDT Allego rises 10.8% - Allego is up 10.8%, or 42c to $4.30.

12:00 EDT Forge Global rises 44.1% - Forge Global is up 44.1%, or $1.52 to $4.97.

11:51 EDT New Age Beverages trading halted, news pending

11:28 EDT AMTD Digital Inc trading resumes

11:22 EDT AMTD Digital Inc trading halted, volatility trading pause

11:12 EDT Nordic American Tankers reports Alexander Hansson's purchase of 175K shares - Alexander Hansson, Board Member of Nordic American Tankers and son of Herbjorn Hansson, the NAT Founder, Chairman and CEO, bought 175,000 shares at $2.3665 per share, the company announced. Following this transaction, Alexander Hansson privately owns 1,925,000 shares, the company reported.

10:30 EDT Knightscope signs contract with Oregon healthcare provider - Knightscope announced that a locally owned healthcare system in Oregon has signed a contract for one of its many facilities in the state. The first deployment will utilize a Knightscope K5 Autonomous Security Robot in a hospital parking lot. The client also has a children's hospital, a 24-hour mental and behavioral health services center, and more than 70 primary care, specialty and urgent care clinics. The hospital's goal is to deter criminal activity, while enhancing patient and staff experience.

10:20 EDT Liquidia Technologies trading resumes

10:14 EDT Southern Company partners with GSA to reduce energy cost at Georgia buildings - The Southern Company system is partnering with the U.S. General Services Administration to increase energy efficiency in 12 federal buildings across Georgia, reducing GSA's carbon footprint and improving overall sustainability. Innovative solutions from the Southern Company system will focus on three key areas - energy efficiency, resiliency and greenhouse gas reductions. Southern Company subsidiaries Atlanta Gas Light and PowerSecure are coordinating the improvements, planned for completion in 2024, and are expected to reduce GSA's annual energy and water costs by nearly $3.3 million. The GSA announced the award of the $117 million Utility Energy Service Contract, which is part of the Biden-Harris Administration's Climate Smart Buildings Initiative. The improvements are expected to enhance building performance and efficiency, while reducing operating costs by approximately 45%. In addition, carbon emissions are expected to be reduced by 18,000 to 21,000 metric tons per year across all 12 GSA buildings.

10:07 EDT SCWorx announces renewal, expansion of contract with New England Hospital - SCWorx announced the renewal and expansion of a data service agreement with an existing 500+ bed hospital in New England. The healthcare provider was previously under a 1 year, $125,000 agreement with SCWorx for data management services. The new agreement is for 4 years, $200,000 per year. The agreement includes currently provided services as well as extended services which are enabled through the normalization, enrichment and integration of data from the hospitals three critical data systems. The utilization of information derived through the integration of data provides the hospital an in-depth analysis as well as cost savings identification through the comparison of data from Supply Chain (Spend), Electronic Medical Records and Finance.

10:03 EDT Weave names Brooke Shreeve Chief People Officer - Weave said it has named Brooke Shreeve as its Chief People Officer. Shreeve has led Weave's People Team since earlier this year and was formally appointed as Chief People Officer by Weave's board in August. Prior to joining Weave in 2020 as the head of HR Business Partners, Shreeve led HR initiatives and operations for organizations ranging in size from 250 to 16,000 employees based in both the U.S. and globally. Companies include Wex Inc., Marketstar, Flying J, Kohls and Sears.

10:00 EDT Borr Drilling falls -7.3% - Borr Drilling is down -7.3%, or -32c to $4.00.

10:00 EDT Azure Power falls -9.7% - Azure Power is down -9.7%, or -57c to $5.28.

10:00 EDT Sequans rises 9.9% - Sequans is up 9.9%, or 34c to $3.73.

09:50 EDT Silver Crest Acquisition, THIL extend termination date to September 30 - In a regulatory filing, Silver Crest Acquisition Corporation disclosed that Silver Crest, TH International Limited and Miami Swan have agreed to extend the termination date as defined in the merger agreement to September 30, 2022, after which either Silver Crest or THIL may terminate the merger agreement. "Silver Crest, THIL and Merger Sub expect to consummate the transactions contemplated by the Merger Agreement following the satisfaction or waiver of the conditions to closing under the Merger Agreement, as described in the definitive proxy statement/prospectus of Silver Crest, which was filed with the SEC on July 21," the filing said.

09:47 EDT Borr Drilling falls -6.5% - Borr Drilling is down -6.5%, or -28c to $4.04.

09:47 EDT Arch Resources falls -6.6% - Arch Resources is down -6.6%, or -$10.82 to $152.86.

09:47 EDT Sequans rises 10.0% - Sequans is up 10.0%, or 34c to $3.74.

09:42 EDT Twitter globally launches Twitter Circle feature - In a tweet, Twitter Safety said, "Today we're rolling out Twitter Circle! This lets you choose on a Tweet-by-Tweet basis who can see your Tweets--everyone or only those in your circle." Reference Link

09:35 EDT Newsight Imaging, Vision Sensing Acquisition enter deal for business combination - Vision Sensing Acquisition Corp. announced execution of definitive business combination agreement with Newsight Imaging, a semiconductor company that develops proprietary 3D machine vision sensors and spectral vision chips. The Combined Company will be led by Eli Assoolin, Newsight Imaging CEO. At the consummation of the proposed business combination, the Company's ordinary shares are expected to be listed on the Nasdaq Capital Market under the ticker symbol "NSIM." Pursuant to the terms of the business combination agreement: a newly-organized, wholly-owned subsidiary of Newsight will merge into VSAC resulting in VSAC becoming a wholly-owned subsidiary of Newsight, Newsight will register as a publicly traded company and parent of VSAC, Newsight's existing shares will be split to facilitate a fully diluted value per Newsight share of US$10, and VSAC's common stock and warrants to purchase VSAC common stock will be exchanged on a one-for-one basis for Newsight Ordinary Shares and warrants to purchase Newsight Ordinary Shares, respectively. Prior to the merger, but subject to the completion of the merger, Newsight will effect a recapitalization of its outstanding equity securities so that the pre-merger holders of Newsight Ordinary Shares and options to acquire Newsight Ordinary Shares will have shares valued at $10.00 per share and having a total value of $215,000,000. This does not include any shares issued as part of any pre-transaction rounds of financing in Newsight. This will result in the pre-merger and pre-financing Newsight shareholders holding approximately 53.6% Newsight Ordinary Shares and options exercisable for just under 3% fully diluted shares, assuming no redemptions by VSAC shareholders, and other assumptions to be set forth in a registration statement to be filed by Newsight on Form F-4 with the U.S. Securities and Exchange Commission. Pre-merger directors, officers and 5% or greater beneficial owners of Newsight Ordinary Shares, with some limited exceptions, will be subject to a lock-up period ending on the earlier of six months from the closing date of the merger and he date on which the closing price of Newsight Ordinary Shares equals or exceeds $12.00 per share for any twenty trading days within any thirty trading day period. In addition to the $102.5 million held in VSAC's trust account, proceeds to the Combined Company in the proposed Business Combination for VSAC and Newsight would potentially include up to US$40 million in pre-transaction financing, a PIPE, or other alternatives. The final amount of any pre-transaction financing, or financing in connection with the proposed business combination, if any, to be raised is by mutual agreement and dependent on market conditions, and related terms, if any, have not been finalized. The Combined Company is expected to receive gross proceeds of up to $143.7 million at the closing of the transaction assuming no redemptions by VSAC's shareholders and an additional financing of up to US$40 million. Net proceeds to the Combined Company are expected to be approximately $140.2 million after transaction-related expenses of approximately US$3.5 million. Use of net proceeds, among other things, are expected to fund research and development, for organic growth and expansion, and for working capital. Assuming no redemptions by VSAC's shareholders, it is estimated that the current shareholders of Newsight will own approximately 53% of the issued and outstanding shares in the Combined Company at closing. As part of the transaction, Newsight's current management and existing equity holders will roll a minimum of 95% of their equity into the Combined Company. The transaction has been approved by each of VSAC's and Newsight's Boards of Directors. The transaction is subject to the approval of VSAC and Newsight shareholders and other customary conditions and is expected to close as early as the fourth quarter of 2022.

09:31 EDT Bright Green signs LOI with Alterola Biotech for partnership, acquisition - Bright Green has signed a letter of intent with Alterola Biotech, a U.K.-based pharmaceutical company focused on developing cannabinoid and cannabinoid-like medicines and products. Bright Green will initially purchase 25% of the issued and outstanding common stock of Alterola for total consideration of $4 million, and will receive a 6 month option to purchase Alterola's remaining issued and outstanding common stock for an additional $6 million and approximately $40 million in Bright Green common stock. As part of the strategic partnership and pursuant to the terms and subject to the conditions of the arrangement, Alterola will gain access to Bright Green's planned cannabis and cannabis extracts, derivatives, products and research services, and Bright Green will in turn benefit from Alterola's established industry relationships and sector expertise. The parties believe a successful collaboration will create a strong pathway to secure, provide and supply cannabis and derivative products to the pharmaceutical industry. The initial $4 million funding is subject to completion of initial satisfactory due diligence and other customary conditions. Closing of the additional proposed arrangement, which will be set forth in a final definitive agreement, shall be subject to several factors, including but not limited to, completion of due diligence to the satisfaction of both parties, provision of cash and stock consideration in connection with the transaction, and timely approval of the arrangement by applicable securities and other regulatory authorities and the stockholders of Bright Green.

09:29 EDT Altamira Therapeutics progressing with plans to focus on RNA business - Altamira Therapeutics provided a business update on its strategic repositioning and key developments in its business. "We continue to be on track with our plan to refocus the Company around our exciting RNA delivery platform and to divest or spin off our legacy business to unlock the intrinsic value of our assets," commented Thomas Meyer, the Company's founder, CEO and Chairman. "Over the past few months, we made great progress in raising awareness of our patented OligoPhore / SemaPhore technology for efficient and safe RNA delivery to extrahepatic target tissues. In addition, we reached important milestones with our nasal spray programs, Bentrio and AM-125, obtaining positive study data for both as well as regulatory clearance for Bentrio in the US and elsewhere. We are making good progress in our efforts to partner both programs, on which we have spent approximately $15 million and $18 million, respectively, to date." Altamira expects to report its first-half 2022 financial results in early October 2022. Preliminary figures show that the Company recorded revenues related to Bentrio of $1.3 million during that period. As previously announced, Altamira's strategy is to commercialize Bentrio globally through well-established OTC consumer health companies with a strong footprint in the respiratory health market, respectively the "allergy" and "cough and cold" categories. While the Company has already established distribution agreements with partners covering most of the important Asian markets except Japan, and the Middle East, the Company's current partnering activities are focusing on the US, EU and other key international markets. Since receiving 510(k) clearance from the US Food and Drug Administration for marketing Bentrio Allergy Blocker, Altamira has advanced partnering discussions with a number of interested parties in a structured process. In this context, the Company has suspended preparations for launching the product in the US on its own as well as major market initiatives in Europe. The US and Europe together represent the largest OTC markets worldwide by far. A larger clinical trial comparing Bentrio with a seawater nasal spray in Australia under "everyday conditions" over 14 days was started in 2021. Positive interim safety and efficacy data from the trial helped to support the successful 510(k) application to the FDA. NASAR is expected to resume enrollment with the upcoming start of the allergy season and to complete the enrollment target of 100 patients for a read-out in Q1 2023. Altamira considers that the spray can also help to reduce the viral load in the nose and the risk of viral infection. However, certain countries and regions require specifically clinical performance data to clear Bentrio for this indication, in particular related to COVID-19. In this context, the Company recently stopped marketing Bentrio in the viral infection indication in the EU and Switzerland and will re-introduce the product in the coming weeks with a labeling for allergy only. COVAMID is a randomized, placebo-controlled clinical trial to evaluate the safety, tolerability, and efficacy of Bentrio in the treatment of acute COVID-19. It began enrolling patients in March 2022. Following a blinded interim analysis, Altamira recently announced that the trial will add 24 patients bringing the total to 160, with top-line data expected in Q4 2022. The Company expects the trial to be essential for supporting its plans to expand Bentrio's product label to include viral infections in those countries and regions requesting such data. In June 2022, the Company announced key results from its TRAVERS phase 2 trial with AM-125, a nasal spray with betahistine as active ingredient for the treatment of vertigo. The trial enrolled a total of 124 patients who suffered from acute vestibular syndrome llowing surgery for the removal of a tumor growing behind the inner ear. TRAVERS demonstrated good safety and tolerability of AM-125 at doses up to 20 mg administered three times daily for four weeks. Further, administration of AM-125 resulted in a dose- and time-dependent improvement in balance and vestibular function. On the primary efficacy endpoint, the improvement in the "Tandem Romberg" balance test, the trial showed a statistically significant increase in the time to failure for the 20 mg dose over placebo. TRAVERS thus served as proof of concept for AM-125 acting as a vestibular stimulant and helping patients to 'get back on their feet' more quickly. Following further analyses of the TRAVERS outcomes, the study team has been drafting an article for publication in a scientific journal. Meanwhile, the Company has been working to move the AM-125 development program forward. Altamira is planning to file an Investigational New Drug application with the FDA in Q4 2022, which will include the protocol for the next clinical trial with AM-125. Benefitting from its intranasal administration route, AM-125 can achieve significantly higher betahistine concentrations in blood plasma than those obtained with the currently available tablets for oral administration. Globally, there has been a dearth of innovation for treating vertigo for decades. In the context of its strategic repositioning, Altamira has initiated partnering discussions on AM-125 with a number of interested parties.

09:24 EDT Prospect Capital to delay release of 10-K; does not expect material impact - In a regulatory NT 10-K filing yesterday evening, the company stated: "Prospect Capital is unable to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2022 within the prescribed time period without unreasonable effort or expense primarily because the Company requires additional time to complete its assessment of the effectiveness of its internal control over financial reporting and the Company's independent registered accounting firm requires additional time to complete its audit of the Company's internal control over financial reporting. Management is in the process of performing an assessment of the effectiveness of the Company's internal control over financial reporting as of June 30, 2022, based upon criteria in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Although the assessment is not yet complete, we expect to report a material weakness in our internal control over financial reporting relating to the operation of management review controls over the valuation of collateralized loan obligations, including management's review procedures over the completeness and accuracy of the underlying data used in performing those review procedures. Additionally, we expect to report a material weakness relating to our control environment and monitoring activities; specifically, with respect to evaluating internal control deficiencies in a timely manner. As a result of the foregoing, the Company needs additional time to finalize its financial statements and related disclosures to be filed as part of the 2022 Form 10-K. The Company expects to file its 2022 Form 10-K within the extension period of 15 calendar days as provided by Rule 12b-25 under the Securities Exchange Act of 1934, as amended. The Company anticipates that the material weaknesses described above will not require a fourth quarter 2022 adjustment or materially impact its consolidated financial statements for any prior annual or interim periods."

09:22 EDT Smart for Life names Benson managing director of Smart Acquisition Group - Smart for Life announced that Stuart Benson, JD, has been named Managing Director of the Company's newly formed subsidiary, Smart Acquisition Group, SAG. SAG is expanding the Company's M&A growth initiatives through the identification, negotiation, financing and acquisition of companies by Smart for Life. Benson most recently served as the Chairman of Ceautamed Worldwide, the owner of the Greens First line of branded products acquired by Smart for Life on July 29, 2022.

09:16 EDT Amesite announces $2.3M registered direct offering - Amesite entered into securities purchase agreements with institutional investors for the purchase and sale of 4,181,821 shares of common stock and warrants to purchase 4,181,821 shares of common stock at a combined purchase price of $0.55. The gross proceeds to Amesite from this offering are expected to be approximately $2.3 million before deducting placement agent fees and other estimated offering expenses. The warrants will be exercisable commencing six months after the date of their issuance, have an exercise price of $0.82 per share and will expire five years from the date of issuance. The offering is expected to close on or about September 1, 2022, subject to customary closing conditions. Laidlaw & Company is acting as sole placement agent for the offering.

09:16 EDT Black Rifle Coffee appoints U.S. Navy veteran Martin Manning as CHRO - Black Rifle Coffee Company has appointed U.S. Navy Veteran and experienced corporate executive Martin "Marty" Manning as Chief Human Resources Officer, CHRO.

09:14 EDT Codiak reports cash, cash equivalents of $41.8M as of June 30 - As of June 30, 2022, Codiak had cash, cash equivalents, and marketable securities of approximately $41.8 million. An essential component of the Company's strategic corporate and partnering discussions and other initiatives is exploring prospective opportunities to provide funding to enable extension of Codiak's cash runway and the potential to resource additional programs.

09:13 EDT Marimed launches Nature's Heritage 'LIVE Flower' - MariMed announced the launch of Nature's Heritage "LIVE Flower," the freshest cannabis flower available. Nature's Heritage "LIVE Flower" buds are bigger and brighter than conventional flower, bursting with more vibrant colors and stronger aromas, and delivering a smoother smoke. "We are very excited about the launch of Nature's Heritage 'LIVE Flower,'" said MariMed Chief Operating Officer Tim Shaw. "Experienced consumers will immediately recognize that our FreshCure curing process delivers the freshest cannabis flower and biggest, brightest, most colorful, and smoothest smoking buds they've ever experienced. The feedback we have received from dispensary owners, budtenders, and influencers has been overwhelming, and we can't wait for people to try it for themselves." Nature's Heritage "LIVE Flower" was launched in Massachusetts this month at MariMed's Panacea Wellness dispensary in Middleborough. It will be distributed through approximately 25 other select dispensaries throughout Massachusetts over the next month.

09:11 EDT Allegiant Travel reports preliminary July traffic up 7.6% y/y - Reports July: Capacity down 3.3%; Passengers up 4.3%; Load factor up 9.2 pts; Departures down 7.8%; Average stage length up 3.8%. All figures for scheduled service on a year over year basis.

09:10 EDT Eyenovia announces Optejet dispenser - Eyenovia brings human-centric design to ophthalmology with its novel Optejet dispenser. Traditional eye drops normally overdose the patient's eye with medication and preservatives Eyenovia's easy-to-use, novel Optejet dispenser administers precisely 8microL of medication to the eye, effectively treating the patient's condition while creating a more gentle dosing experience.

09:09 EDT Vertex wins U.S. Navy contract valued up to $230M - The Vertex Company, a V2X company, was awarded a contract valued up to $230 million for contractor logistics support for the U.S. Navy and U.S. Marine Corps' fleet of C-12 Huron aircraft. The C-12 is a twin-engine aircraft used for light passenger and cargo missions. Under the new contract, Vertex will provide a range of services including site support, aircraft depot maintenance, engine depot maintenance, propeller depot overhauls and modifications.

09:08 EDT Benefitfocus announces Advanced Engagement Services solution - Benefitfocus announced Advanced Engagement Services, a personalized and action-oriented communications solution that helps employers and health plans create a more connected and engaging benefits experience. Benefitfocus' Advanced Engagement Services leverage artificial intelligence to provide a multichannel experience for helping people better engage with their benefits and navigate the health care system. The solution is the first of its kind in that it enables highly secure communications and sharing of information without requiring individuals to download or log in to a portal, which can act as a barrier to engagement. Benefitfocus estimates that customers can achieve engagement rates two-to-three times higher than through typical communications and digital engagement tactics.

09:07 EDT TrueCar forecasts 1,152,846 new vehicle sales in August, up 9% y/y - TrueCar expects total new vehicle industry sales to reach 1,152,846 units in August 2022, up 9% from a year ago and slightly up from July 2022, when adjusted for the same number of selling days. This month's seasonally adjusted annualized rate for total light vehicle industry sales is an estimated 13M, down 14% from August 2021. Excluding fleet sales, TrueCar expects U.S. retail deliveries of new cars and light trucks to be 1,015,575 units, up 6% from a year ago and up about 3% from July 2022.

09:06 EDT Freyr Battery up 11.5% in pre-market trading after announcing Nidec JV - Shares of Freyr Battery are up 11.5% or $1.45 in pre-market trading at $14.10 after the company announced that it has signed a joint venture agreement for battery energy storage products with Nidec overnight.

09:06 EDT Fiverr announces partnership with Shutterstock - Fiverr announced a partnership with Shutterstock to integrate its vast content of licensed assets on its platform. The integration will provide freelancers who offer digital services on Fiverr instant and easy access to millions of licensed assets for commercial use.

09:05 EDT Dick's Sporting expands resale partnership with SidelineSwap - DICK'S Sporting Goods and SidelineSwap are expanding their partnership to offer a series of 50 new trade-in events in seven states through the end of 2022. DICK'S Sporting Goods and SidelineSwap have previously held 10 successful trade-in events at four DICK'S locations.

09:04 EDT Nucor to invest $200M in South Carolina sheet and beam mill - Nucor announced that it will invest $200M over a 5-year period in mill modernization projects at its Nucor Steel Berkeley division located in Huger, South Carolina. Pending permit and regulatory approvals, a portion of the capital investment will include the construction of a new air separation unit for the purpose of supplying industrial gases for the mill's steelmaking operations. When complete, the ASU will be operated by UIG LLC, a Nucor wholly owned subsidiary, that specializes in industrial gas supply. Nucor Steel Berkeley is currently supplied with industrial gases under a long-term supply agreement. This project will allow Nucor through UIG to produce and supply all the gases needed for the steel mill from the new Nucor owned facility, both now and into the future.

09:03 EDT Heartland BancCorp to open new branch in Delaware, Ohio - Heartland BancCorp announced that a nineteenth Heartland Bank branch will be located at 1754 Columbus Pike in Delaware, Ohio. With a groundbreaking planned for mid-September of 2022, this branch will be situated in the Delaware Community Plaza. The style will mirror the universal branch model in several current locations and include a night drop, drive-thru and ATM. The space is being designed to include a community room for small gatherings and casual meetings. Plans currently suggest a twelve-month construction timeframe with an anticipated open date in the late summer of 2023.

09:02 EDT Matterport introduces Matterport Pro3 Camera with updates - Matterport introduced the all-new Matterport Pro3 Camera along with major updates to its digital twin cloud platform. The Pro3 is a breakthrough in 3D capture technology, ready to digitize every aspect of the physical world, indoors and outdoors. Matterport's next generation digital twin platform builds on the company's groundbreaking immersive virtual experiences to enable advanced workgroup collaboration and productivity, delivering cost savings and revenue growth for organizations of all sizes, from small businesses to global enterprises.

08:58 EDT Global Ship Lease announces forward charter agreements - Global Ship Lease announced that it has entered into new multi-year charters with Hapag-Lloyd for six ECO 6,900 TEU ships. The new charters are each for a firm period of five years, followed by two 12 month periods at the option of the charterer, and are scheduled to commence between late 2023 and late 2024, following the expiration of existing charters to a different counterparty. The charters are expected to generate average Adjusted EBITDA of approximately $13.1 million per ship, per year; and total Adjusted EBITDA of around $393 million for the six ships over the firm charter period.

08:46 EDT Forza X1 begins design process on high-powered electric outboard motor - Forza X1 announced that its engineering team has begun a project to design a new, larger horsepower outboard motor, targeted to perform up to 400 HP continuous and 600 HP peak equivalents.

08:44 EDT Greenlane regains compliance with Nasdaq listing requirements - Greenlane Holdings received notice from The Nasdaq Stock Market on August 24, 2022 informing Greenlane that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Global Market. Consequently, Greenlane is now in compliance with all applicable listing standards and its Class A common stock will continue to be listed on The Nasdaq Global Market. Greenlane was previously notified by Nasdaq on February 25, 2022 that it was not in compliance with the minimum bid price rule because its Class A common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive business days. To regain compliance with the minimum bid price rule, the Company was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days. This requirement was met on August 24, 2022, the eleventh consecutive trading day that the closing bid price of the Company's Class A common stock was over $1.00.

08:43 EDT Medigus says Gix reports 1H rvenues of $43.4M vs. $16.3M last year - "Increasing our ownership in Gix, was one of our main focuses over the past year, mainly due to our trust in Gix's ability to grow. We are excited about Gix's financial results and believe in its future and its continued growth", commented Liron Carmel, Medigus Chief Executive Officer.

08:42 EDT Willis Lease subsidiary selected by Peach Aviation Limited - Willis Lease Finance announced that its wholly owned subsidiary, Willis Asset Management, has been selected by Peach Aviation Limited as its dedicated aircraft CAMO provider in support of A320 aircraft redeliveries taking place at various Maintenance, Repair & Overhauls, MROs, in Asia and Europe. "Willis Lease, and our subsidiaries, are well placed to support our customers with fleet transitions due to our broad capabilities, ranging from CAMO and airframe maintenance to fleet purchases and engine exchanges. We are honored to have been selected by Peach and look forward to exceeding their expectations," said Austin Willis, CEO of Willis Lease.

08:41 EDT Greenlane regains compliance with Nasdaq - Greenlane announced that it received notice from Nasdaq informing Greenlane that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on The Nasdaq Global Market. Consequently, Greenlane is now in compliance with all applicable listing standards and its Class A common stock will continue to be listed on The Nasdaq Global Market.

08:39 EDT PowerFleet reaches 3,000 industrial segment customers - PowerFleet announced that it has crossed the threshold of 3,000 industrial segment customers and grew its revenue by 12 percent in the US industrial market for the first half of 2022, compared to the prior year period. The milestone cements PowerFleet's position as the market leader in the Industrial telemetry segment of the IoT market and is an indicator that the industry is increasingly seeking enterprise technology solutions to drive improved safety and productivity across business operations. PowerFleet is also expanding at pace its Industrial solution capabilities for launch into Latin America, Israel and the Middle East, as well as developing further into Europe.

08:39 EDT Gulf Resources expects 2023 bromine and crude salt segment revenues to increase - Based on information currently at hand, revenues and earnings in 2023 for bromine and crude salt segments are projected to increase from the estimates in 2022. The Company currently believes that 2023 will benefit from: The production of factory #8, which may add approximately by 20% to annual production capacity of operating factories at this time; More days of additional production. With Chinese New Year coming earlier in 2023, there will be more production days in the first quarter, and with Chinese New Year coming later in 2024 there should be more production days in the 4th quarter; Fewer closings for inspections as if COVID is expected to abate somewhat; Continued strength in pricing, as the closure of many factories has lowered supply, while the decline of the RMB versus the USD and other currencies has made imports more expensive; The Company also believes it may get permission to open another factory in 2023, but this factory is not included in these projections.

08:38 EDT Gulf Resources sees Q3 bromine and crude salt segment revenue $20M-$21.8M - For the third quarter ending 9/30/2022, the bromine and crude salt segments are projected to generate revenues of approximately $20.0 million to $21.8 million, an increase of approximately 12.4% to 22.5% from that of the previous year. Profit before income tax is expected to be approximately $ 9.0 million to $10.3 million, an increase of approximately 20.0% to 37.3% from that in the previous year.

08:38 EDT BOS Better Online Solutions' Supply Chain Division receives $850,000 order - BOS Better Online Solutions announced that its Supply Chain Division has received an order in the amount of $850,000, for delivery during year 2023.

08:37 EDT MyMD receives grant from European patent office for Supera-CBD compound - MyMD Pharmaceuticals, announced that it received a decision to grant from the European Patent Office in its application no. EP 3755318 A1. The allowed claims cover MyMD's Supera-CBD compound as a new molecular entity and pharmaceutical formulations containing the compound. "We are excited that another major patent office has acknowledged the superior ability of Supera-CBD to selectively bind with the CB2 receptor, which could potentially offer a breakthrough drug for the treatment of indications such as pain and anxiety," commented Chris Chapman, M.D., President, Director, and Chief Medical Officer. "This news, along with the ongoing clinical development of lead compound, MYMD-1, demonstrates the continued progress MyMD has made this year in advancing these two products." MYMD-1, an oral selective inhibitor of tumor necrosis factor-alpha, TNF-alpha, that drives chronic inflammation, is being studied to slow the aging process, prevent sarcopenia and frailty, and extend healthy lifespan. A Phase 2 multi-center double-blind, placebo controlled, randomized study (NCT05283486) to investigate the efficacy, tolerability and pharmacokinetics of MYMD-1 in the treatment of chronic inflammation associated with sarcopenia/frailty is currently ongoing. The company's scientific review committee met recently and agreed to move to the next higher dose in the study. The upcoming patent grant adds to the company's growing portfolio that already includes patents in the US, Australia, Canada, Israel, and South Korea for Supera-CBD and its therapeutic uses.

08:36 EDT OSI Systems receives $22M security division order - OSI Systems announced that its security division has received an order valued at approximately $22M to provide comprehensive service, maintenance, and spare parts support for various Rapiscan cargo and vehicle inspection systems deployed internationally.

08:35 EDT Hall of Fame Resort & Entertainment sells The Perfect 10 sports documentary - Hall of Fame Village Media announced it has sold the long-anticipated sports documentary, The Perfect 10, and that it will co-produce the film with Fox Sports Films, which shines a spotlight on the only 10 football icons who have achieved winning the Heisman Trophy and being enshrined in the Pro Football Hall of Fame.

08:34 EDT Nuo Therapeutics provides corporate, business update - Nuo Therapeutics announced an initial corporate and business update since re-establishing fully available commercial operations in the second quarter of this year. Notable recent highlights include: An equity agreement with Pacific Medical, Inc. dated August 24, 2022 by which Pacific Medical will purchase $500,000 of Nuo common stock and potentially acquire up to 1,250,000 additional shares of Nuo common stock in conjunction with a broader arrangement that substantially incentivizes the Pacific Medical team to deliver strong performance in the distribution and sale of the Aurix product. The Current Report on Form 8-K filed today by Nuo with the SEC describes more fully the equity opportunities tied to sales milestones that should support the alignment of Nuo and Pacific Medical efforts to provide patient access to the Aurix System. Distribution agreements are in place with ten separate entities, the largest of which is Pacific Medical having in excess of 40 representatives with experience in the blood-based biologics and wound care space. These distributor partners are now fully trained on the Aurix product and are beginning engagement with potential physician and hospital facility customers. Including the $500,000 investment from Pacific Medical noted above, Nuo has raised approximately $4.5 million in working capital equity this year which Nuo believes is sufficient to position the Aurix product as a foundational cash flow positive asset. This investment will allow Nuo to deliver effective clinical outcomes in the treatment of chronic wounds, while substantially advancing the business opportunity and positioning Nuo for future success. As a result of the resumption of Nuo's periodic financial reporting with the Securities and Exchange Commission, Nuo applied and has been approved for quotation and trading on the OTCQB Venture Market tier at www.otcmarkets.com. While being focused on business execution presently, Nuo believes that an uplisting to a national securities exchange will be a viable option at the appropriate time. There can be no assurance however that a successful listing on a national securities exchange will take place. The re-launch of a commercially available Aurix product became possible due to the April 2021 issuance of the favorable national coverage decision for blood-based products that have an FDA indication for use in the management of chronic wounds. Market estimates for 2022 indicate the North American market for advanced wound care products will total approximately $3.6 billion while the prevalence of the three major chronic wound etiologies - diabetic foot ulcers, venous ulcers, and pressure ulcers - continues to increase. The size of the U.S. population expected to have diabetes is estimated to exceed 40 million individuals by the early 2030's and nearly 20% of Medicare age diabetes patients have non-healing foot ulcers. Due to the increasing prevalence of chronic wounds, the advanced wound care market in the U.S. appears poised for continued change as the increasing spend in the space has not translated into improved healing on a broad scale. Centers for Medicare & Medicaid Services has recently proposed changes to the overall mechanism for Medicare reimbursement of cellular and tissue-based products, commonly referred to as skin substitutes, that could have a significant impact on the usage and delivery of advanced therapy products in the future.

08:27 EDT Siyata Mobile announces ramp up for SD7 devices, accessories - Siyata Mobile announces that it is in the process of ramping up sales of its next-generation MCPTT SD7 device, as well as the VK7 and Rapid Kit companion devices to numerous customers across multiple verticals including private security firms, police, emergency medical services, National Guard, school districts, hospitals/health clinics, a major theme park and others. In addition, demos have started or are about to begin with a defense contractor, several state patrols and various government agencies. In addition multiple trials are now converting into initial deployments of the SD7 and its companion products, the VK7 and Rapid Kit, and the Company expects to receive larger purchase orders as customers continue to engage with the product.

08:24 EDT Biomerica plans launch of InFoods IBS test, names Carlson CCO - Biomerica announced plans to launch its InFoods IBS test before calendar year end. The test will be performed in a CLIA-certified, high-complexity laboratory facility and offered as a laboratory developed test. The Company further announced it has hired Robert Carlson to serve as the Company's Chief Commercial Officer, CCO, in preparation for the launch of InFoods IBS. Following the successful completion and positive results from the Company's InFoods IBS clinical trial, Biomerica has received significant interest from Gastroenterology physicians who would like to order the InFoods IBS test for their patients immediately. Therefore, in parallel with the Company's existing strategy to seek FDA marketing authorization, it is now also preparing to launch InFoods IBS as an LDT through a CLIA-certified, high-complexity laboratory, to provide patient test results to assist GI physicians in treating their IBS patients. The commercial launch of the InFoods IBS test is expected before calendar year-end 2022. Carlson will manage the immediate logistics of the LDT launch, and drive the mid-term InFoods IBS commercialization strategy including national reimbursement and FDA marketing authorization. Carlson is the former Chief Commercial Officer, Vice President and head of sales, marketing, and corporate development at Prometheus Laboratories.

08:22 EDT Immutep granted Japanese patent for eftilagimod alpha - Immutep announced the grant of a new patent entitled "Combined Preparations for the Treatment of Cancer or Infection" by the Japanese Patent Office. This new Japanese patent follows the grant of the corresponding Australian, European, United States and Chinese patents announced in 2018 through 2022. The claims of the new patent protect Immutep's intellectual property relating to combined therapeutic preparations comprising its lead active immunotherapy candidate eftilagimod alpha, which is a LAG-3 fusion protein, and an anti-PD-(L)1 antibody. The claims are also directed to related methods of use in the treatment of cancer and infection. In addition to broader style claims, the granted claims include narrower claims drawn to specific combinations of efti with various approved PD-(L)1 antibodies. In all, the claims provide comprehensive coverage of both combination products and combination therapies comprising efti and an anti-PD-(L)1 antibody. The patent expiry date is 8 January 2036.

08:21 EDT Paysafe appoints Alex Gersh as new CFO - Paysafe has appointed Alex Gersh as its new Chief Financial Officer. Gersh joins the company on October 3, 2022, and will report into Paysafe CEO, Bruce Lowthers. "Gersh joins Paysafe from Sportradar, the leading global sports technology company creating immersive experiences for sports fans and bettors, where he built a high performing finance function and successfully led the company's IPO on NASDAQ in September last year" said the statement

08:20 EDT Arteris IP collaborates with SiMa.ai to optimize ML implementation - Arteris announced its collaboration with SiMa.ai integrating the Arteris highly adaptable FlexNoC interconnect IP into the SiMa.ai Machine Learning System-on-Chip. The joint work enables customers to meet the high speed and low latency requirements necessary for implementing AI/ML computing at the edge. Arteris interconnect IP capabilities enable SiMa.ai's SoC and ML accelerator IPs to connect seamlessly and efficiently, which is critical to delivering a push-button experience that SiMa.ai customers need.

08:20 EDT Evolus names Sandra Beaver as CFO - Evolus has named Sandra Beaver as its Chief Financial Officer, effective September 5. Ms. Beaver brings more than 20 years of financial experience, driving company growth through strategic planning, long-range forecasting, executing corporate development and capital markets transactions, and improving operational efficiency.

08:19 EDT EzFill announces geographic expansion into West Coast Florida market - EzFill Holdings announced the expansion in the West coast of Florida, specifically the Gulf of Mexico region of Tampa Bay. "In a very short amount of time, we have been able to secure over 11 brand new fleet customers to our service offering. This includes one of the largest grocers within the country where our service commitment to them includes hundreds of thousands of gallons of fuel per year covered by two fills per day, seven days per week," says EzFill Chief Commercial Officer, Rick Dery. "After only several weeks, the EzFill portfolio of business in the Tampa Bay area includes servicing over 160 commercial vehicles that will utilize approximately 600,000 gallons of fuel per year ... and we're continuing to grow." continued Dery.

08:18 EDT AMD Pensado DPUs to support VMware vSphere 8 - AMD (AMD) announced that the AMD Pensando Distributed Services Card will be one of the first DPU solutions to support VMware (VMW) vSphere 8 available from leading server vendors including Dell Technologies, HPE and Lenovo.

08:18 EDT First Solar to invest up to $1.2B to scale production of PV solar modules - First Solar announced that it plans to invest up to $1.2B in scaling production of American-made, photovoltaic, or PV, solar modules, directly supporting the country's transition to a decarbonized future and enabling the fight against climate change. The investment is forecast to expand the company's ability to produce American-made solar modules for the U.S. solar market to over 10 gigawatts, or GW, DC by 2025. As part of its push to scale U.S. production of solar modules, the company intends to build its fourth, fully vertically integrated domestic factory, with an annual capacity of 3.5 GWDC, in the U.S. Southeast. First Solar, the only US-headquartered company among the world's ten largest solar manufacturers, expects to invest up to $1B in the new factory, which, contingent upon permitting and pending approval of various federal, state, regional, and local incentives, is expected to commence operations in 2025. Additionally, the company will invest $185M in upgrading and expanding its Northwest Ohio manufacturing footprint, currently the largest vertically-integrated complex of its kind in the Western Hemisphere, by 0.9 GWDC. As part of its plans, First Solar will invest in expanding the capacity of its two operating facilities in Perrysburg and Lake Township, Ohio, by 0.6 GWDC to 3.6 GWDC of annual Series 6 module capacity. The company will also expand its third Ohio factory, expected to be commissioned in the first half of 2023, to 3.5 GWDC of annual Series 7 module capacity. The expansion will increase First Solar's total investment in its Ohio manufacturing facilities to over $3B, with a cumulative annual production capacity of over 7 GWDC by 2025. First Solar estimates that the new investment will add at least 850 new manufacturing jobs, taking its total number of direct jobs in the US to over 3,000 people in four states by 2025, which is believed to make it the largest employer in the American solar manufacturing sector. By 2025, First Solar is also expected to support an estimated 15,000 indirect and induced jobs as a result of its ongoing and future manufacturing operations.

08:16 EDT DZS announces availability of M4000 edge aggregation, mobile transport system - DZS announced the availability of its M4000 high-performance edge aggregation and mobile transport system. The M4000 offers Software Defined Networking enabled flexibility for both 5G xHaul and network edge traffic aggregation applications. Optimized for network edge deployments with a compact form factor and environmentally hardened design, the DZS M4000 supports advanced low-latency high-capacity switching, synchronization and Quality of Service requirements for complex 5G and Open RAN networks.

08:13 EDT Th Floow expands North American team to support business growth - Otonomo Technologies announced that The Floow has expanded its team across strategy, sales, client services and marketing to drive continued growth and support of the North American market. Following its acquisition by Otonomo in early 2022, The Floow has seen strong demand for the fusion of connected vehicle data and cutting-edge mobile technology that will radically transform the insurance industry. To support business expansion, The Floow has announced the appointments of Jim Cook as vice president of North American sales, Julie Sehrt as senior director of client development, Luciana Chamberlain as product marketing manager and Scott Himowitz as marketing programs manager. The Floow also announced the promotion of Danny Maco to senior vice president of commercial lines and U.S. strategic products.

08:11 EDT Twitter says Musk's purported termination 'invalid and wrongful' under agreement - As previously disclosed, on July 8, Twitter received a notice of purported termination of the agreement and plan of merger, dated as of April 25, by and among X Holdings I, X Holdings II, a wholly owned subsidiary, and, solely for the purpose of certain provisions of the merger agreement, Elon R. Musk. The merger agreement provides that, subject to the terms and conditions set forth in the agreement, the acquisition sub will merge with and into Twitter, with Twitter surviving the merger and becoming a wholly owned subsidiary of parent, which is wholly owned by Mr. Musk. On August 29, Twitter received another notice of purported termination of the merger agreement, the company disclose in a regulatory filing. In a response to that second notice of termination, lawyers for Twitter stated in part: "As was the case with your July 8, 2022 purported notice of termination, the purported termination set forth in your August 29, 2022 letter is invalid and wrongful under the Agreement... It is based solely on statements made by a third party that, as Twitter has previously stated, are riddled with inconsistencies and inaccuracies and lack important context. Contrary to the assertions in your letter, Twitter has breached none of its representations or obligations under the Agreement, and Twitter has not suffered and is not likely to suffer a Company Material Adverse Effect. Twitter intends to enforce the Agreement and close the transaction on the price and terms agreed upon with the Musk Parties." Reference Link

08:09 EDT Sunrun delivers over 80 MW of stored solar energy capacity to California Grid - Sunrun announced that it delivers more than 80 megawatts of stored solar energy capacity from customer batteries to the state's electric grid daily to reduce strain and improve energy resilience for all Californians. This is significantly larger than California's controversial Ellwood gas-fired peaker plant, as well as several other highly polluting peaker plants across the state. Sunrun's customers collectively support California's grid every day by providing additional energy capacity during times of peak demand. During just one recent event, more than 17,000 Sunrun customers made available over 80 MW of stored energy capacity during the standard Time of Use window - a 60% increase in capacity over the previous year - which supports the overall health of California's electric grid with clean solar energy every day.

08:09 EDT VMware, IBM expand partnership to modernize hybrid cloud environments - VMware (VMW) and IBM (IBM) announced at VMware Explore 2022 an expanded partnership to help global clients and partners modernize workloads and expedite time-to-value in hybrid cloud environments. The expanded relationship includes IBM Consulting as a VMware GSI partner, the companies' intent to deliver new jointly engineered IBM and VMware Cloud solutions, and joint development and go to market. Together, IBM and VMware are planning to help clients in regulated industries such as financial services, healthcare and public sector address the cost, complexity, and risk of migrating and modernizing mission-critical workloads in the cloud. Companies, including those in regulated industries, are looking to modernize core business workloads to create better experiences for their clients and comply with industry regulations. Further, the current economic climate makes refactoring applications for cloud unrealistic for many organizations, driving increased emphasis on a more agile modernization strategy. The planned IBM and VMware offerings are intended to increase choice and flexibility for companies to execute their digital transformation strategies.

08:08 EDT Chipotle to test Chicken Al Pastor in select markets - Chipotle Mexican Grill announced it is testing Chicken Al Pastor at 94 restaurants in Denver and Indianapolis. Available now for a limited time, Chicken Al Pastor features the bold yet balanced flavor of spicy adobo, achiote, morita peppers, pineapple, cilantro and fresh lime juice.

08:07 EDT Outlook Therapeutics resubmits BLA for ONS-5010 - Outlook Therapeutics announced it has re-submitted its Biologics License Application to the U.S. Food and Drug Administration for ONS-5010, an investigational ophthalmic therapy which, if approved, will be branded as LYTENAVA for the treatment of wet age-related macular degeneration. In anticipation of potential FDA marketing approval in 2023, Outlook Therapeutics has continued its commercial launch planning. These activities include establishing partnerships with FUJIFILM Diosynth Biotechnologies for drug substance, and with drug product manufacturer Ajinomoto Bio-pharma Services for finished drug product. Outlook Therapeutics is also actively building out its distribution and commercial capabilities.

08:06 EDT Boxed partners with TerraCycle for first ongoing recycling program - Boxed (BOXD) has partnered with international recycling leader TerraCycle, to give customers a way to recycle where they shop. Through the partnership, sponsored by Procter & Gamble (PG), Boxed customers can recycle any brand of home essentials and personal care products. "With the launch of this first-of-its-kind national recycling initiative, Boxed is providing consumers with the unique opportunity to responsibly recycle their packaging and divert waste from landfills," said TerraCycle CEO and Founder, Tom Szaky. "Consumers everywhere can now conveniently buy their necessities in bulk, but not at the expense of the planet."

08:05 EDT Cybin doses first participants in CYB003 trial - Cybin announced that the first two participants have been dosed in its Phase 1/2a trial evaluating CYB003 for the treatment of major depressive disorder, or MDD.

08:05 EDT LiqTech says Fei Chen to start CEO role on September 12 - LiqTech announced that the company's newly appointed President and CEO, Fei Chen, will commence her employment on September 12. The previous announcement specified a start date on or before November 1, and we are fortunate that she has received an early release from her present employer. Effective September 12, Chen will also be appointed a member of the company's Board of Directors.

08:04 EDT Kraft Heinz to divest B2B powdered cheese business to Kerry Group - Kraft Heinz announced that it has entered into a definitive agreement to sell its B2B powdered cheese business to global food, beverage and pharma manufacturer Kerry Group. The proposed transaction is expected to close in the second half of 2022, subject to regulatory review and approval. The transaction involves the divestiture of Kraft Heinz's B2B powdered cheese products, which are sold through the company's Ingredients business. This divestiture includes the Albany, Minnesota, manufacturing facility, which is expected to operate in ordinary course. Employees at the Albany location will be transferred from Kraft Heinz to Kerry Group. The divestiture of the B2B powdered cheese business reflects the company's ongoing and active portfolio optimization.

08:03 EDT Harmoni agrees to acquire Parallel from funds managed by Apollo Global - Harmoni Towers, a portfolio company of Palistar Capital, an alternative asset manager, announced that it has agreed to acquire Parallel Infrastructure, a leading tower platform and build-to-suit provider, from funds managed by affiliates of Apollo Global Management. Terms were not disclosed. The transaction is subject to customary closing conditions and is expected to be completed in the Q3. The transaction creates the fifth largest tower company and the second largest private independent tower company in the U.S., with more than 2,000 built and in-construction towers. The combined company will have locations spanning the country from coast-to-coast across 41 states, with the capacity to build hundreds of towers per year in all regions of the U.S. Palistar and Hamoni were advised by Kirkland & Ellis, while Apollo and Parallel were advised by Weil, Gotshal & Manges.

08:03 EDT Connect Biopharma successfully completes CBP-174 Phase 1 SAD study - Connect Biopharma announced it successfully completed its first-in-human Phase 1 study of CBP-174 designed to evaluate safety, tolerability, and pharmacokinetics in healthy adults. CBP-174, a highly selective, peripherally acting H3 receptor antagonist drug candidate is in development to treat pruritus associated with allergic and inflammatory skin diseases, including atopic dermatitis. CBP-174 administered orally, was observed to be safe and well-tolerated across eight dose escalation cohorts evaluated up to a maximum dose of 16 mg or placebo in this randomized, double-blind, placebo-controlled, single ascending dose, SAD, study. There were no serious adverse events, and reported adverse events were predominantly mild in severity and no dose-limiting toxicities were identified. Other safety parameters, including vital signs, ECGs, and laboratory results showed no clinically notable safety findings. "This promising first human data demonstrates good progress for CBP-174 as a novel treatment for pruritus associated with allergic and inflammatory skin conditions, such as atopic dermatitis, which afflicts millions of individuals worldwide," said Dr. Zheng Wei, Ph.D., Co-Founder and CEO of Connect Biopharma. "This is our first clinical trial for our third clinical-stage drug candidate, and we look forward to continuing the evaluation of CBP-174 as we work toward improving the quality-of-life outcomes for patients with debilitating dermatologic diseases."

07:43 EDT Rekor Systems selected for launch of multi-year program with TxDOT - Rekor Systems announced that it has been selected for the launch of a multi-year program with the Texas Department of Transportation for a deployment of its traffic management technology to improve incident response time and overall roadway safety. The contract calls for the implementation of Rekor's cloud-based roadway intelligence platform at the TxDOT Combined Transportation, Emergency, and Communications Center facilities. The platform uses artificial intelligence and integrates date from multiple sources to provide more comprehensive and quicker incident identification than current methods.

07:40 EDT Monarch Mining announces drilling program results from its Swanson gold project - Monarch Mining reports that it has received more high-grade results from the 2021-2022 drilling program on its wholly-owned Swanson gold project. Comprising a contiguous group of 127 map-designated claims and one mining lease covering an area of 5,125.8 ha, the Swanson property lies 65 kilometres northeast of Val-d'Or, Quebec, and just 50 kilometres north of Monarch's wholly owned 750-tonne per day Beacon mill. The 2021-2022 program is the first drilling done on the property since Monarch Gold acquired it from Agnico-Eagle Mines in 2017. "We have now managed to define the plunge-trend of the Swanson gold deposit and are continuing to intersect significant high-grade gold mineralization beyond the currently defined mineral resource envelope," said Jean-Marc Lacoste, President and Chief Executive Officer of Monarch. "We are confident that the remaining drill holes will also yield positive results."

07:39 EDT Entourage Health signs four new union groups to Starseed Medicinal program - Entourage Health announces its medical subsidiary Starseed Medicinal has added four new union groups to its full-service, proprietary medical cannabis program, in partnership with leading benefits provider Union Benefits - the administrator of union group benefits to over 12,000 members. The medical cannabis plan, which goes into effect September 1, 2022, provides eligible union members and their dependents access to practitioners specializing in prescribing medical cannabis as an insured benefit. "We congratulate and proudly welcome our four newest member unions and their locals to our full-service Starseed medical platform. Together, we are removing the barriers to access medical cannabis as an alternative therapy for members and benefits provider Union Benefits, looking to responsibly educate and provide treatment options to patients for a myriad of indications," said George Scorsis, CEO and Executive Chair, Entourage. "Our simplified and personalized treatment plans are curated alongside our award-winning healthcare experts who carefully ensure patients have access to a portfolio of over 45 trusted medical cannabis products including, soft-gel capsules, oils, soft-chews, patches, compounds, vapes, and dried flower. As a result of these widely accepted therapeutic alternatives, coupled with a seamless reimbursement process, we now have over 10 union groups, five insurance providers, and 24 clinics signed to our Starseed platform."

07:38 EDT TxDOT standardizes Rekor's cloud-based roadway intelligence platform - Rekor Systems announced that it has been selected for the launch of a multi-year program with the Texas Department of Transportation or TxDOT, for a deployment of its traffic management technology to improve incident response time and overall roadway safety. The contract calls for the implementation of Rekor's cloud-based roadway intelligence platform at the TxDOT Combined Transportation, Emergency, and Communications Center CTECC facilities. The platform uses artificial intelligence and integrates date from multiple sources to provide more comprehensive and quicker incident identification than current methods."Improving the safety of transportation infrastructure in Texas starts with better real-time detection and understanding of the state's roadway traffic trends and changes," said Rekor President, David Desharnais. "We are pleased to help TxDOT and other agencies within Texas achieve this with our comprehensive roadway intelligence platform and actionable insights to improve traffic congestion and respond to incidents and crashes that impact the safety of its citizens." Rekor Systems to deploy loud-based AI-driven Roadway Intelligence Platform

07:36 EDT Palantir, MCI Onehealth enter three-year commercial agreement - MCI Onehealth and Palantir Technologies are pleased to confirm a three-year commercial agreement to power MCI's clinical insights that can improve patient outcomes and help address urgent health system issues. Palantir's Foundry platform will power analytics for improved MCI patient care and research projects for MCI's international stakeholders in the health, pharma, therapeutic, and life sciences sectors. The partnership with Palantir supports and helps accelerate MCI's partnerships with other health innovators like MDClone. MCI's collaboration with Palantir will continue to accelerate MCI's data strategy in disease screening, novel referral optimization and other custom data and precision medicine initiatives. Health researchers can access MCI generated insights to better understand disease progression, enhance care delivery and develop new products and treatments that can improve patient outcomes - which can help reduce overall health system costs. This is possible by leveraging MCI's rigorous data governance controls and Palantir Foundry's embedded data protection capabilities, including granular access controls, end-to-end provenance, and audit, which ensures MCI can secure sensitive health data, while enabling access to only authorized users for approved purposes.

07:34 EDT AIM ImmunoTech, Roswell Park starts enrollment in trial evaluating Ampligen - AIM ImmunoTech announced its clinical development collaborator, Roswell Park Comprehensive Cancer Center, in a clinical trial fully funded by the National Cancer Institute, NCI, has commenced patient enrollment in its Phase 2 study in subjects with primary PD-1/PD-L1 resistant melanoma. The Phase 2 study will evaluate type-1 polarized dendritic cell vaccine in combination with tumor-selective chemokine modulation, CKM, comprised of Interferon alpha 2b, Ampligen and Celecoxib. "The start of this NCI-funded clinical trial marks an important milestone for our Melanoma R&D program. Despite recent successes of immune checkpoint inhibitors in advanced-stage disease, only a minority of treated melanoma patients have a durable benefit, reinforcing the need to develop second-line therapies that are effective against checkpoint-refractory disease. Based on the data seen to-date, we believe Ampligen, in combination with Roswell's polarized dendritic cell vaccine plus interferon, has an opportunity to fill this gap and potentially provide clinical benefit to melanoma patients in need," commented AIM Chief Executive Officer Thomas Equels. The single-arm Phase 2 study plans to enroll up to 24 subjects. Subjects will be on active experimental treatment for 12 weeks. In the absence of disease progression, patients will be followed for progression-free survival and overall survival within routine care. Patients with progressive disease at 12 months can, at the physician's discretion, begin CTLA-4+/- PD-1/PDL1 inhibitor treatment and will be followed as per standard of care for this disease group. Patients will continue to be monitored for PFS and OS within standard care visits. The primary endpoint of the study is objective response rate at 12 weeks, which will be evaluated using RECIST 1.1 criteria.

07:32 EDT Air Products and ABP partner to build green hydrogen facility in the UK - Air Products and Associated British Ports, or ABP, announced their intention to partner in bringing the first large scale, green hydrogen production facility to the UK. The facility would import green ammonia from production locations operated by Air Products and its partners around the world. This would be used to produce green hydrogen, which would decarbonise hard-to-abate sectors such as transport and industry. The UK Government has plans for 10GW of low-carbon hydrogen to be in production or construction by 2030. Air Products and ABP are working together to bring the new green hydrogen facility to the Port of Immingham. The location will provide the required maritime infrastructure and offers good proximity to markets and the required utilities. ABP will invest in new infrastructure with a new jetty to service the import and export handling of liquid bulk products.

07:16 EDT Mobilicom announces closing of initial public offering - Mobilicom announced the closing of its U.S. initial public offering of 3,220,338 units, including 362,338 units sold upon full exercise of the underwriter's option to purchase additional units, each consisting of one American Depository Share and one warrant to purchase one ADS, at a public offering price of $4.13 per unit for gross proceeds of approximately $13.3 million, before deducting underwriting discounts and offering expenses. The warrants have a per ADS exercise price of USD $5.00, are exercisable immediately and expire five years from the date of issuance. The Company intends to use the proceeds of the offering for expansion of its sales and marketing activities, research and development, and working capital. ThinkEquity acted as sole book-running manager for the offering.

07:13 EDT Winners' VegasWinners launches Facebook, Instagram ad campaign - Winners announced that its subsidiary VegasWinners has launched its Facebook & Instagram ad campaign to substantially increase its database of sports gamblers to materially increase subscription and referral based Income with the start of the College and NFL football seasons.

07:10 EDT C3Nano secures $35M in growth capital financing - C3Nano announced the completion of a $35M growth capital financing, comprised of equity and debt. The equity financing was led by Element Solution. New debt financing was provided by insured technology financing pioneer, PIUS Limited. The growth capital will enable C3Nano to expand its Hayward, California-based silver nanowire synthesis and production capacity, as well as add resources to accelerate its efforts to innovate and commercialize its nanowire-based technologies.

07:09 EDT HEXO to produce Mike Tyson's TYSON 2.0 in Canada - HEXO announced that the Company has entered into an exclusive partnership with TYSON 2.0, entrepreneur and cannabis advocate Mike Tyson's recently formed cannabis company. Under the agreement, HEXO will produce TYSON 2.0's products in Canada, including TYSON 2.0's full range of flower, pre-rolls, edibles and vapes. The HEXO-produced lines will launch across Canada in fall 2022.

07:07 EDT Lithium Ionic reports drilling resultsfrom Galvani claims - Lithium Ionic reports additional excellent drilling results from the Galvani claims, on which it is currently conducting a due diligence review following the recently announced binding asset purchase agreement. The Galvani claims, as well as the Company's neighbouring 100%-owned Itinga Lithium Project are located in the state of Minas Gerais, Brazil, in the same district as the lithium producing CBL mine and Sigma Lithium's Barreiro deposit. New Galvani Drill Results Highlights: Drill intercept of 1.94% Li2O over 19.78m, incl. 2.33% Li2O over 7.35m; Drill intercept of 1.27% Li2O over 10.77m, incl. 1.72% Li2O over 2m and 1.70% Li2O over 3.53m. Previously Reported Drill Result Highlights from Galvani Target: Drill intercept of 1.57% Li2O over 24.93m, incl. 2.10% Li2O over 7.45m; Drill intercept of 1.17% Li2O over 42.05m, incl. 1.95% Li2O over 11.72m. Blake Hylands, Chief Executive Officer of Lithium Ionic, commented, "The latest drill results at the Outro Lado showing at the Galvani claims are very encouraging and further demonstrates the potential for us to define a significant deposit in this area. We continue to improve our understanding of the geology and mineralization controls, which will enable us to define new targets."

07:07 EDT Gambling.com ready for online sports betting launch in Kansas - Gambling.com announced it is ready to provide marketing services to licensed online sports betting operators in the state of Kansas as soon as the legal online sports betting market soft launches on Thursday, September 1st, one week ahead of the 2022 NFL season.

07:06 EDT Osisko Mining provides updated MRE for its Windfall gold deposit - Osisko Mining provides an updated mineral resource estimate, MRE, for its 100% owned world-class high-grade Windfall gold deposit, located in the Abitibi greenstone belt, Urban Township, Eeyou Istchee James Bay, Quebec. This robust MRE includes approximately 1.9M metres of drilling, with 1.7M metres completed by Osisko since October 2015, completed as of May 2022 and all analytical results received as of June 7, 2022. The MRE will form the basis of the pending Windfall Project Feasibility Study, scheduled for delivery by YE2022. Chief Executive Officer of Osisko John Burzynski commented: "We've had a busy summer and have successfully completed another significant milestone at Windfall. With this final MRE update prior to our pending feasibility study, we have met and exceeded our objectives for the Windfall drill program: a robust measured and indicated resource of over 4 million ounces with an average grade of over 10 g/t Au. The scale of Windfall and the deposit grade has steadily increased since Osisko's discovery of Lynx in late 2016. Lynx now represents almost two-thirds of the total gold in the MRE, and it continues to impress with a stand-alone total M&I resource of 3.1 M oz averaging 13.0 g/t Au."

07:05 EDT Getty Images, Verizon partner to increase representation of disabilities - Getty Images (GETY), together with Verizon (VZ), have announced the recipients of a $40,000 creative grant focused on sharing the voices, experiences and stories of disability communities. Getty Images' VisualGPS global research shows that despite around 20% of people globally living with some form of visible or invisible disability, only 1% of visuals in media and advertising include a person living with a disability, with wheelchairs overwhelmingly being the primary indicator of someone having a disability. Despite the ongoing gap in representation, a look at search data from Getty Images' most popular visuals shows that there is an increasing interest in visuals of people with disabilities in work and community settings, with searches related to disability growing above other trends. "The traditional standard for visualizing people with disabilities in media and advertising is in need of a refresh to authentically reflect the diversity of relationships within the broader community," said Dr. Rebecca Swift, Creative Grant Judge and Global Head of Creative Insights at Getty Images. "We are pleased to support creators working to capture the real experiences of real communities."

07:04 EDT Apollo Silver increases marketing activities - Apollo Silver is pleased to announce that it has engaged 121 Group to help build Company awareness and increase exposure within the global mining investment community. The services will include media relations, investor engagement, content dissemination and other investor relations services, via the 121 Group's vetted investor network, which will be provided by a team based primarily in London, England. Pursuant to the agreement, 121 Group will commence services effective September 1, 2022, for an initial six-month term, which may be terminated with 30 days notice following the initial minimum contract period. 121 Group will receive a monthly fee of $3,500 for their services. After the initial contract period, the agreement will continue, if agreed upon by both parties, on a month-by-month basis. 121 Group is an arm's length party to the Company and, to the Company's knowledge, does not currently own any securities of the Company, but may purchase securities of the Company from time to time for investment purposes. The Company's agreement with 121 Group is subject to acceptance from the TSX Venture Exchange.

07:03 EDT springbig partners with JARS Cannabis, Plant.Body.Soul to host celebration - springbig announced its first collaborative event with JARS Cannabis, a multi-state operating cannabis brand. Set to take place on September 16 in Phoenix, the joint event will celebrate Arizona's top cannabis brands while emphasizing the importance of co-marketing between cannabis brands and retailers. "Enjoying the success of our latest collaborative event with Planet 13, springbig is excited to partner with JARS and Plant.Body.Soul. on this inclusive activation. The cannabis industry is always better when we're working together for a common goal," said Jeffrey Harris, springbig CEO.

07:00 EDT Senstar Technologies awarded two contracts worth over $2M collectively - Senstar has been awarded two significant contracts in the energy sector in the USA and Canada that are valued at over $2M and aim to reinforce the security of several major strategic sites.

06:47 EDT Albemarle to realign Bromine, Lithium global business units - Albemarle announced that it will realign its Bromine and Lithium global business units, or GBU, into a new corporate structure. The move follows the recent announcement of the company's decision to reorganize Catalyst under a to-be-named, wholly owned subsidiary. Organizational changes for Albemarle Specialties and Albemarle Energy Storage are expected to be effective January 1, 2023. Beginning in 2023, the company will financially report through the following segments: energy storage, specialties, and catalysts.

06:46 EDT International Game extends contract with New York Lottery - International Game announced that its subsidiary, IGT Global Solutions Corporation, signed a four-year contract extension with the New York Lottery. This agreement extends the current contract to August 2026.

06:39 EDT Musk tells Twitter new allegations provide additional bases to end deal - Tesla (TSLA) CEO Elon Musk disclosed that on August 29, his advisors sent a letter to Twitter (TWTR) formally notifying Twitter that he is terminating their merger agreement "for additional bases separate and distinct from those bases set forth" in the July 8 letter to Twitter terminating their merger agreement on that date. "Because the facts described in the August 29 Termination Letter were known to Twitter and withheld from the Reporting Person, and because Twitter has taken the position that the Merger Agreement remains in effect, the Reporting Person sent the August 29 Termination Letter on the basis of the facts described therein," Musk wrote this morning in a regulatory filing. In the letter to Twitter, Musk wrote, "Allegations regarding certain facts, known to Twitter prior to and as of July 8, 2022, but undisclosed to the Musk Parties prior to and at that time, have since come to light that provide additional and distinct bases to terminate the Merger Agreement. Although the Musk Parties believe this termination notice is not legally necessary to terminate the Merger Agreement because they have already validly terminated it pursuant to the July 8 Termination Notice, the Musk Parties are delivering this additional termination notice in the event that the July 8 Termination Notice is determined to be invalid for any reason." The letter references the August 23 report from the Washington Post regarding the Twitter whistleblower. The Zatko complaint "alleges far-reaching misconduct at Twitter-all of which was disclosed to Twitter's directors and senior executives, including Parag Agrawal-that is likely to have severe consequences for Twitter's business," wrote Musk to Twitter.

06:35 EDT Bed Bath & Beyond over 9% in pre-market, remains most active on Stocktwits - Shares of Bed Bath & Beyond remain volatile, rising 9.6% in early pre-market trading following yesterday's 24.8% gain. The stock remains the most active trending name in terms of message volume on Stocktwits this morning.

06:32 EDT Abacus Life to go public via merger with East Resources Acquisition - Abacus Settlements and Longevity Market Assets and East Resources Acquisition Corporation announced their entry into a definitive merger agreement that will result in Abacus becoming a publicly listed company. Upon closing of the transaction, the combined company will be named Abacus Life, Inc. and is expected to remain listed on Nasdaq under the new ticker symbol "ABAL." The combined company will have an estimated post-transaction enterprise value of $618M, assuming no redemptions by ERES public stockholders. Cash proceeds from the transaction will consist of up to $98M of cash held in ERES's trust account, plus any additional cash raised via a private placement prior to closing of the transaction. The net proceeds from the transaction will enable Abacus to lower its cost of capital, scale its Hold Portfolio and begin securitizing policy portfolios. Abacus owners will roll 100% of their existing equity holdings into the combined company and are expected to own approximately 70% of the combined company on a non-fully diluted basis immediately following the closing of the transaction, assuming no redemptions by ERES's public stockholders. The transaction, which has been unanimously approved by the boards of both ERES and Abacus, and has the voting support of all of the equity holders of Abacus, is expected to close as early as the fourth quarter of 2022, subject to regulatory approvals, approval of the proposed transaction by stockholders of ERES and the satisfaction or waiver of other customary closing conditions. Following the closing of the transaction, the existing management team of Abacus, led by CEO Jay Jackson, will continue to operate and manage Abacus.

06:16 EDT Babylon Holdings reports strong feedback from survey with GP at Hand patients - Babylon announced results from a recent independent survey where the company received strong feedback ratings from its GP at Hand NHS patients and scored in the 90th percentile for the majority of responses. From the thousands of patients surveyed who provided positive reviews for our GP practice, including our doctors, appointments and overall process, the survey results show Babylon's digital-first model benefits patients. Babylon is re-engineering healthcare by moving away from a reactive model of sick care, which is designed to deal with crises and emergencies, to a data-centric, predictive, proactive healthcare service that continuously monitors patients' health, predicts health concerns and intervenes to avoid unwanted illness. The GP Patient Survey is independently run by Ipsos MORI on behalf of NHS England and reaches over two million individuals across the UK. The results revealed that of Babylon's surveyed GP at Hand patients 96% had confidence and trust in the healthcare professional, compared to the 93% national average.

06:10 EDT Greenbrier announces Thomas Fargo as independent chair - Greenbrier announced the election of retired four-star Admiral Thomas Fargo as independent chair of its board of directors, effective at Greenbrier's close of business on August 31. A board member since 2015, Fargo serves as chair of Greenbrier's Compensation Committee and a member of the Nominating and Corporate Governance Committee. Fargo has served as the company's lead director since January 2021, a position Greenbrier's board will eliminate with the election of an independent board chair. Effective with the appointment of Fargo, Greenbrier's board policy is that members identified as chair must meet the standards of the SEC and NYSE for an independent director.

06:08 EDT YouTube chief business officer Robert Kyncl to depart - In a Monday tweet, YouTube's CBO Robert Kyncl said, "YouTube is a great place to be at, and a great place to be from! After 12 incredible years, I've decided to move on to the next challenge soon. Working alongside creators, artists, media and music companies to transform media has been a privilege".Reference Link

06:05 EDT Big Lots sees Q3 comparable store sales down in low double-digit range - The company said, "For the third quarter, the company expects one-year comps to be down in the low double-digit range. Net new stores will add about 140 bps of growth versus 2021. The company expects continued significant promotional activity in Q3, resulting in a quarter gross margin rate into the mid-30s, and that SG&A dollars will grow low single-digits to 2021. Given an atypically wide range of outcomes, the company is not providing EPS guidance at this point. The company expects a share count of approximately 28.9 million for Q3. The company is taking aggressive actions to significantly improve the gross margin rate in Q4, to a rate that is approximately in-line with the prior year quarter. In addition, the company will continue to take actions to reduce expenses."

05:34 EDT Schlumberger, Aker Solutions and Subsea 7 announce joint venture - Schlumberger, Aker Solutions and Subsea 7 announced an agreement to form a joint venture to drive innovation and efficiency in subsea production by helping customers unlock reserves and reduce cycle time. The agreement will bring together a portfolio of technologies such as subsea gas compression, all-electric subsea production systems and other electrification capabilities that help customers meet their decarbonization goals. The proposed joint venture will combine Schlumberger's and Aker Solutions' subsea businesses, which include deep reservoir domain and engineering design expertise, a field-proven subsea production and processing technology portfolio, manufacturing scale and capabilities, and a suite of life-of-field solutions for customers all over the world. Subsea 7 will be an equity partner in the new joint venture. Upon closing of the proposed transaction, the existing Subsea Integration Alliance between Schlumberger and Subsea 7, will be amended so that the new joint venture will assume Schlumberger's role in the Alliance, which will be renewed for a ten-year term. In addition to contributing its subsea business to the joint venture, at closing Schlumberger will issue to Aker Solutions shares of Schlumberger common stock valued at $306.5M in a private placement. Concurrently, Subsea 7 will purchase its 10% interest in exchange for $306.5M in cash to Aker Solutions. The joint venture also will issue a promissory note to Aker Solutions for $87.5M. At closing of the joint venture, Schlumberger will own 70%, with Aker Solutions owning 20% and Subsea 7 owning 10%. The transaction is subject to regulatory approvals and other customary closing conditions and is expected to close in the second half of 2023.

05:28 EDT Accenture invests in Pixxel, terms undisclosed - Accenture has made a strategic investment, through Accenture Ventures, in Pixxel, an earth imaging technology company. Based in Bangalore with a presence in Los Angeles, Pixxel is building the world's highest resolution hyperspectral imaging satellite constellation in order to offer industry AI-powered insights that discover, solve, and predict climate issues at a fraction of the cost of traditional satellites. Pixxel's first commercial phase satellites are scheduled to be launched in early 2023 along with the commercial sale of its data.

05:25 EDT Freyr, Nidec sign joint venture agreement for battery energy storage products - Nidec (NJDCY) signed a joint venture agreement with Freyr Battery (FREY). Freyr is planning to start mass production in 2024. Freyr has semi-solid lithium-ion battery manufacturing technology in terms of quality and manufacturing process. The company will manufacture batteries in Norway, an advanced decarbonization country, exclusively using clean renewable hydroelectric power locally available. Consequently, Freyr 's production of battery cell is environmentally friendly, and it gains competitive advantage in terms of abundant energy supply and lower cost coupled with lower CO2 emissions. Nidec's Battery Energy Storage Solutions, or BESS, provide services to the grid that enable accelerated adoption of renewable power generation which contributes to the realization of a carbon-zero society. Freyr will manufacture eco-friendly semi-solid lithium-ion batteries using 100% renewable energy through a dedicated power purchase agreement with Statkraft based on 100% hydroelectric power. Nidec's partnership with Freyr will ensure a procurement of semi-solid lithium-ion batteries for Nidec's BESS solutions. The objective of the alliance is to jointly create a provider of utility scale battery energy storage products drawing on Freyr's low-carbon battery technology and Nidec's position in utility scale energy storage systems. By concluding this joint venture agreement, Nidec will strengthen strategic partnership with FREYR and aim to further expand the BESS solution business in the future. In parallel, Nidec continues to work on strengthening its partnerships with leading lithium-ion battery suppliers in order to secure our needs for battery products and support growth in the coming years.

05:16 EDT Orange, Equinix announce collaboration on Bare Metal as a Service capability - Orange (ORAN) and Equinix (EQIX) announced a collaboration to expand the Orange Telco Cloud footprint, using Equinix's Bare Metal as a Service capability, Equinix Metal, to speed the deployment of Orange's New Generation International Network. The new model enables Orange to provide business and wholesale customers with on-demand Telco Cloud Points of Presence, or PoPs, delivering essential services such as SD-WAN, CDN, 5G roaming and voice services, with an expected latency below 10 milliseconds. Three locations will be deployed by the end of this year: Amsterdam, Madrid and Seattle.